The GB Pharma Group is not only a CRO (Clinical Research Organisation) but also a CSO (Contract Safety Organisation) and Regulatory Affairs Services Company.

Our Mission

We are customer oriented and focusing to the unmet needs of our present and future customers.

Customers goals are also one of our goals. We strive for simplicity, selectivity and continuous performance optimization.

High performance, both as individuals and as group. We deliver on ambitious goals, and grow by developing our talents and Personal Leadership.

Thanks to the professional expertise in the pharmaceutical environments reached by its founder and the company personnel, GB Pharma Group is the ideal partner for a wide range of services in:

  • Clinical Research
  • Observational/Outcome Research Studies
  • Pharmacovigilance
  • Regulatory Affairs

Supporting customers product development, newly authorized or marketed products related activities.

The added value consists in customer strategic support through all the Clinical and Regulatory activities leading to the placing on the market of the drug.

 

Strategic business development consulting in the pharmaceutical market (Licensing IN-OUT) is an additional “PLUS”.

GB Pharma Group is able to support its customers both in the business development and growth and in the market strategic decision for the identification of new business areas.

GB Pharma Group is also a Market Authorization Holder and so is a “Pharmaceutical Company” with its own:

  • PSMF
  • Eudravigilance subscription

For that, it can be “Applicant” for the National and European registration on behalf of the customers.